23 results
8-K
EX-99.1
NEO
Neogenomics Inc.
30 Apr 24
NeoGenomics Reports First Quarter 2024 Results
7:32am
Way | Fort Myers, FL 33912
Page | 3
operational efficiency, returning to profitable growth and its ongoing executive recruitment process. Each
8-K
EX-99.1
NEO
Neogenomics Inc.
20 Feb 24
NeoGenomics Reports Fourth Quarter and Full Year 2023 Results
4:06pm
growth and its ongoing executive recruitment process. Each forward-looking statement contained in this press release is subject to a number of risks
8-K
EX-99.1
NEO
Neogenomics Inc.
6 Nov 23
NeoGenomics Reports Third Quarter 2023 Results
4:18pm
, including statements regarding improving operational efficiency, returning to profitable growth and its ongoing executive recruitment process. Each
8-K
EX-99.1
0e8d9x8ed
8 Aug 23
NeoGenomics Reports Second Quarter 2023 Results
7:03am
8-K
EX-99.1
rr91w
8 May 23
NeoGenomics Reports First Quarter 2023 Results
4:10pm
8-K
EX-99.1
mkt5a66mqng6joszyx
4 Apr 23
Regulation FD Disclosure
2:54pm
8-K
EX-99.1
381u80
5 Dec 22
NeoGenomics Announces Chief Financial Officer Transition
9:40pm
8-K
EX-99.1
lstxggowr3tk0 2wb
8 Nov 22
NeoGenomics Reports Third Quarter 2022 Results
7:07am
8-K
EX-99.1
e5ocdbz8r73 kj
7 Nov 22
Departure of Directors or Certain Officers
4:54pm
8-K
EX-99.1
et66cc16cpiry
9 Aug 22
NeoGenomics Reports Revenue of $125 Million in the Second Quarter
7:05am
8-K
EX-99.1
893ny6np27a7siv3u
16 May 22
NeoGenomics Appoints Lynn Tetrault Interim CEO
10:13am
8-K
EX-99.1
9gt1xajxbr 038s1nlb
11 May 22
NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary
5:02pm
8-K
EX-99.1
1p6f1 catc
27 Apr 22
NeoGenomics Reports Revenue of $117 Million in the First Quarter
7:19am
424B5
qhbuidj9migd x6y
10 Aug 18
Prospectus supplement for primary offering
10:09am
424B5
ow5g0jx7p7tsdiu
6 Aug 18
Prospectus supplement for primary offering
4:59pm